Background illustration for clinical trials search

Paid Clinical Trials Colorado Springs

Discover 431 paid clinical trials in Colorado Springs, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

for
Breast Cancer, Gastric Cancer, Esophageal Cancer,
Location: Littleton CO, Dallas TX, Houston TX, Nashville TN,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06695845

Phase 2, Recruiting

Prospective Study to Assess a Diagnostic Aid for Cancer

for
Cancer
Location: Centennial CO, Hutchinson KS, Oklahoma City OK,
Sponsor: Harbinger Health

Sex: All

Age: 45+

Code: NCT07046260

Recruiting

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Location: Centennial CO, Kansas City KS, Kansas City MO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05327114

Phase 2, Phase 3, Recruiting

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

for
Attention-Deficit/Hyperactivity Disorder
Location: Centennial CO, Las Vegas NV, Plano TX, Imperial CA,
Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All

Age: 4 - 5

Code: NCT04781140

Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for
Uterine Fibroids, Endometriosis
Location: Greenwood Village CO, Lakewood CO, Aurora CO,
Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Oral Nutrition Impact on Tear Film

for
Dry Eye Syndrome
Location: Conifer CO, Creve Coeur MO, Oak Lawn IL, Lexington KY
Sponsor: Eye and Vision Technologies and Research Institute

Sex: All

Age: 18 - 70+

Code: NCT01561040

Recruiting

Integrated Cancer Repository for Cancer Research

for
Pancreatic Cancer, Thyroid Cancer, Lung Cancer,
Location: Greenwood Village CO, North Platte NE, Hastings NE,
Sponsor: University of Nebraska

Sex: All

Age: 19 - 70+

Code: NCT02012699

Recruiting

Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

for
Hiatal Hernia
Location: Denver CO, Austin TX, Lexington KY, Mobile AL,
Sponsor: Tela Bio Inc

Sex: All

Age: 22+

Code: NCT07070115

Recruiting

Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control

for
Chronic Pain, Intractable Pain, Low Back Pain,
Location: Greenwood CO, Corpus Christi TX, New Orleans LA,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07190807

Recruiting

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

for
Pain
Location: Greenwood Village CO, Shreveport LA, Regina,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT01719055

Recruiting

EffectiveNess and SAfety of Small ANeurysm COiling Trial

for
Aneurysm
Location: Englewood CO, Oklahoma City OK, Minneapolis MN,
Sponsor: University of Virginia

Sex: All

Age: 18 - 70+

Code: NCT02167997

Recruiting

Change 4 Better (C4B)

for
Problem Gambling
Location: Denver CO, Norwalk CT, Waterbury CT, New Haven CT,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06963931

Recruiting

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Denver CO, Dallas TX, San Antonio TX, Nashville TN,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07372625

Phase 1, Recruiting

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

for
Parkinson Disease
Location: Aurora CO, Kansas City KS, Round Rock TX,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 40 - 70+

Code: NCT06976268

Phase 2, Phase 3, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Englewood CO, Sandy City UT, Salt Lake City UT,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase 2, Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for
Dystonia
Location: Denver CO, Albuquerque NM, Scottsdale AZ,
Sponsor: Vima Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07304089

Phase 2, Recruiting

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

for
Acute Hereditary Angio Edema
Location: Centennial CO
Sponsor: Octapharma

Sex: All

Age: 2+

Code: NCT06361537

Phase 3, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Englewood CO, Aurora CO, Scottsdale AZ, Dallas TX,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Denver CO, Aurora CO, Salt Lake City UT, Westwood KS,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase 3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Englewood CO, Aurora CO, Salt Lake City UT, Lubbock TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting